PB Handbook for Psychiatric Trainees
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2000) 24: 172-174. doi: 10.1192/pb.24.5.172
© 2000 The Royal College of Psychiatrists
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, S.
Right arrow Articles by Henderson, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Smith, S.
Right arrow Articles by Henderson, M.
Psychiatric Bulletin (2000) 24: 172-174
© 2000 The Royal College of Psychiatrists

What you don't know won't hurt you

Information given to patients about the side-effects of antipsychotic drugs

Shubulade Smith, Research Fellow and Honorary Senior Registrar

Institute of Psychiatry, De Crespigny Park, London SE5 8AF

Max Henderson, Senior House Officer

Maudsley Hospital, Denmark Hill, London SE5 8AZ


   Abstract
 Top
 Abstract
 Introduction
 The study
 Findings
 Comment
 References
 
AIMS AND METHOD

Information given to patients about side-effects of their medication plays a key role in future adherence. It is possible that when antipsychotic medication is prescribed routinely, insufficient information is given to them. In order to investigate the amount of information doctors feel they need to give to patients when they are prescribing conventional antipsychotic medication, all the clinical doctors at a large mental health trust were surveyed by anonymous questionnaire.

RESULTS

Overall, doctors said they gave large amounts of information to patients about possible side-effects of anti-psychotic drugs, but some side-effects we discussed far more frequently than others.

CONCLUSIONS

The selectivity of information given to patients appears to reflect the doctors perception of what is important. This might not correlate with what the patient may wish to be told. Discussions with patients about side-effects may need to be more comprehensive than they currently are.


   Introduction
 Top
 Abstract
 Introduction
 The study
 Findings
 Comment
 References
 
Traditional antipsychotic medications have a wide range of adverse effects (British National Formulary, 1997) some of which have been found to occur more commonly than others, for example, extrapyramidal symptoms (Peuskens, 1995; Tollefson et al 1997). Movement disorders are generally accepted to be the most common side-effects of antipsychotic medications, although it has been pointed out that other side-effects may be as common or as serious and thus as likely to cause non-adherence with medication (Lidsky et al, 1981).

Keown et al (1984) found that lay-people were keen to be informed of all potential side-effects of medication. It has also been found that patient education about potential side-effects may be more likely to improve adherence rather than result in the patient refusing to take the drug (Howland et al, 1990). Chaplin et al (1998) found low rates of non-adherence in patients who attended educational sessions about the side-effects of antipsychotic drugs. Thus, it is possible that there is a link between lack of information about adverse effects and subsequent patient non-adherence. In order to investigate this, we tried to ascertain how much information doctors give to their patients about side-effects, by asking them which of the adverse effects of traditional antipsychotics they routinely discuss with patients and which side-effects they discuss only if the patient asks about them or complains of that side-effect.


   The study
 Top
 Abstract
 Introduction
 The study
 Findings
 Comment
 References
 
All doctors working clinically at a large mental health trust in south London, were sent a questionnaire asking them about the side-effects they routinely inform patients of when prescribing conventional antipsychotic medication, for example, chlorpromazine and haloperidol. Responses possible were: ‘always/sometimes’ (unprompted discussion) or ‘only if the patient asks of that side-effect’ (prompted discussion). A score of one was given for unprompted discussion, a score of zero for prompted discussion. This gave an overall total score which could range from 0-23. For example, a score of 15 indicates that that doctor informs patients about 15 of the listed adverse effects, without prompting, most of the time. Doctors who failed to return questionnaire within four weeks were sent a further copy. The speciality, years working in psychiatry, membership of the Royal College and grade were noted for each doctor.


   Findings
 Top
 Abstract
 Introduction
 The study
 Findings
 Comment
 References
 
One hundred and twenty-one questionnaires were returned out of a total of 205 (59%). Breakdown of the speciality, years in psychiatry and membership of the Royal College of Psychiatrists can be seen in Table 1.


View this table:
[in this window]
[in a new window]
 
Table 1 Characteristics of doctors responding to questionnaires

 

No significant differences were found between different grades with regard to overall scores on the questionnaire. However, senior registrars reported giving more information than senior house officers/registrars, who reported giving more information than consultants. Forensic specialists reported informing patients of more side-effects than other specialists, and this approached significance (P=0.06), but numbers were very small. There was no correlation between score on the questionnaire and length of time in psychiatry, being a member of the College or grade.

Table 2 shows the side-effects of conventional medications with the numbers of doctors who discuss each side-effect either unprompted (sometimes or always) or prompted (only if the patient asks or complains). Some of the questionnaires were filled out incompletely, so in the case of certain side-effects there were less than 121 responses.


View this table:
[in this window]
[in a new window]
 
Table 2 Side-effects of conventional antipsychotic medications

 

Dry mouth, blurred vision and Parkinsonism were the most frequently discussed side-effects, with weight gain, blood disorders, jaundice and temperature regulation problems being discussed less often. There was a marked discrepancy in the frequency of the type of discussion of different side-effects. This can be seen in Table 3, which shows the percentage of time spent on either prompted or unprompted discussion for each set of side-effects. This was produced by grouping together individual side-effects and for each group summing the reports of prompted or unprompted discussion, then dividing by the total number of opportunities for discussion, for example, anticholinergic affect being discussed unprompted was 114+112+99+72=397; 397/(121+121+118)=397/480=82.7%. Thus, doctors reported that when they discuss anticholinergic side-effects, 83% of the time they did so without the patients having to ask.


View this table:
[in this window]
[in a new window]
 
Table 3 Percentage prompted/unprompted discussion of different groups of side-effects

 


   Comment
 Top
 Abstract
 Introduction
 The study
 Findings
 Comment
 References
 
We must draw attention to the limitations of the study. It is a purely descriptive study relying on honest reporting by doctors. This is perhaps a poor proxy for actually being present at a consultation. The response rate was only 59% and we do not know the habits of those who did not return the questionnaires which may be quite different to those of the responding doctors. The study took place at a large teaching trust with a high proportion of middle grade doctors which may make the sample unrepresentative. How reliable the responses were might be questioned given that 10% claimed to routinely tell their patients about ocular pigmentation and one in three routinely discuss glaucoma!

The indications of this study are that doctors report that they do inform patients about the adverse effects of medication, but it appears they are highly selective with regard to which side-effects they feel ready to discuss with patients.

Anticholinergic and extrapyramidal side-effects are generally considered to be the most commonly occurring side-effects, most likely to result in non-adherence if they occur without the patient having some under-standing of why they occur and how to combat them. However, other side-effects such as cardiac effects, weight gain and sexual side-effects have been found to be very troublesome and common (Keks, 1996). That these side-effects may be causes of non-adherence has yet to be investigated. Tollefson et al (1997) found weight gain to be one of the most frequent patient complaints, more so than the extrapyramidal side-effects. Cardiac toxicity has been implicated in many of the non-deliberate sudden deaths associated with neuroleptic medications (Warner et al, 1996), yet it appears from this study that doctors are relatively unlikely to inform patients of these potentially fatal adverse effects.

It seems logical that side-effects which are felt to be less common are less frequently discussed with patients, such as skin photosensitivity and menstrual dysfunction, however, it is possible that clinicians underestimate the prevalence of these side-effects as patients do not complain.

This study highlights the selectivity of information given to patients by doctors about their medication. Clearly prospective studies need to be done to investigate the possibility that there may be differences in perception between doctors and patients with regard to the importance of side-effects and also to research the relationship between iatrogenic antipsychotic-induced dysfunction and non-adherence. The important first step, however, should be to improve the discussions with patients about the side-effects of antipsychotic drugs.


   References
 Top
 Abstract
 Introduction
 The study
 Findings
 Comment
 References
 
BRITISH NATIONAL FORMULARY (1997) British National Formulary. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain.

CHAPLIN, R. (1998) Informing patients about tardive dyskinesia. Controlled trial of patient education. British Journal of Psychiatry, 172, 78-81.[Abstract/Free Full Text]

HOWLAND, J. S. BAKER, M. G. & POE, T. (1990) Does patient education cause side effects? A controlled trial. Journal of Family Practice, 3, 62-64.

KEKS, N. A. (1996) Minimising the non-extrapyramidal side-effects of antipsychotics. Acta Psychiatrica Scandinavica, 389 (suppl.), 18-24.

KEOWN, C., SLOVIC, P. & LICHTENSTEIN, S. (1984) Attitudes of physicians, pharmacists and laypersons towards seriousness and need for disclosure of prescription drug side-effects. Health Psychology, 3, 1-11.[Medline]

LIDSKY, T. J., LABUSZEWSKI, T. & LEVINE, F. M. (1981) Are movement disorders the most serious side effects of maintenance therapy with antipsychotic drugs. Biological Psychiatry, 16, 1189-1194.[Medline]

PEUSKENS, J. (1995) Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. British Journal of Psychiatry, 166, 712-726.[Abstract/Free Full Text]

TOLLEFSON, G. D., BEASLEY, C. M., TRAN, P., et al(1997) Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry, 154, 457-465.[Abstract]

WARNER, J. P., BARNES, T. R. & HENRY, J. A. (1996) Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatrica Scandinavica, 93, 311-313[Medline]




This article has been cited by other articles:


Home page
Adv. Psychiatr. Treat.Home page
R. Chaplin, P. Lelliott, A. Quirk, and C. Seale
Negotiating styles adopted by consultant psychiatrists when prescribing antipsychotics
Advan. Psychiatr. Treat., January 1, 2007; 13(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
S. SMITH, V. O'KEANE, and R. MURRAY
Sexual dysfunction in patients taking conventional antipsychotic medication
The British Journal of Psychiatry, July 1, 2002; 181(1): 49 - 55.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, S.
Right arrow Articles by Henderson, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Smith, S.
Right arrow Articles by Henderson, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals